Abstract:Background: Resveratrol have been known to possess many pharmacological properties including antioxidant, cardioprotective and anticancer effects. Although current studies indicate that resveratrol produces neuroprotection against neurological disorders, the precise mechanisms for its beneficial effects are still not fully understood. We investigate the effect of anti-inflammatory and mechamisms of resveratrol by using lipopolysaccharide (LPS)-stimulated murine microglial BV-2 cells.Methodology/Principal Findings: BV-2 cells were treated with resveratrol (25, 50, and 100 mu M) and/or LPS (1 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of PTEN (phosphatase and tensin homolog deleted on chromosome 10), Akt, mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs) cascades, inhibitor kappa B-alpha (I kappa B-alpha) and cyclic AMP-responsive element-binding protein (CREB) were measured by western blot. Resveratrol significantly attenuated the LPS-induced expression of NO, PGE2, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and nuclear factor-kappa B (NF-kappa B) in BV-2 cells. Resveratrol increased PTEN, Akt and mTOR phosphorylation in a dose-dependent manner or a time-dependent manner. Rapamycin (10 nM), a specific mTOR inhibitor, blocked the effects of resveratrol on LPS-induced microglial activation. In addition, mTOR inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of I kappa B-alpha, CREB, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK).Conclusion and Implications: This study indicates that resveratrol inhibited LPS-induced proinflammatory enzymes and proinflammatory cytokines via down-regulation phosphorylation of NF-kappa B, CREB and MAPKs family in a mTOR-dependent manner. These findings reveal, in part, the molecular basis underlying the anti-inflammatory properties of resveratrol.

Inhibition Of 26s Protease Regulatory Subunit 7 (Mss1) Suppresses Neuroinflammation

Rifampicin Inhibits Microglial Inflammation and Improves Neuron Survival Against Inflammation.

Downregulation of Mir-199B Promotes the Acute Spinal Cord Injury Through IKKβ-NF-κB Signaling Pathway Activating Microglial Cells.

Rifampicin Ameliorates Lipopolysaccharide-Induced Cognitive And Motor Impairments Via Inhibition Of The Tlr4/Myd88/Nf-Kappa B Signaling Pathway In Mice

Investigations into the Role of 26s Proteasome Non-Atpase Regulatory Subunit 13 in Neuroinflammation

Rifampicin Attenuates Rotenone-Treated Microglia Inflammation Via Improving Lysosomal Function.

Rifampicin Improves Neuronal Apoptosis in LPS-stimulated Co-Cultured BV2 Cells Through Inhibition of the TLR-4 Pathway

Rifampicin Attenuates Rotenone-Induced Inflammation Via Suppressing NLRP3 Inflammasome Activation in Microglia

Rifampicin Inhibits Rotenone-Induced Microglial Inflammation Via Enhancement of Autophagy.

RNA interference silencing P2X7 receptor restrained inflammatory factors released from the microglia

Propofol Inhibits Microglial Activation Via Mir-106B/pi3k/akt Axis.

Overexpression of SIRT1 Induced by Resveratrol and Inhibitor of miR-204 Suppresses Activation and Proliferation of Microglia

Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312)

Resveratrol Inhibits Inflammatory Responses Via The Mammalian Target Of Rapamycin Signaling Pathway In Cultured Lps-Stimulated Microglial Cells

Rhynchophylline Attenuates LPS‐induced Pro‐inflammatory Responses Through Down‐regulation of MAPK/NF‐κB Signaling Pathways in Primary Microglia

Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.

Small nucleolar RNA host gene 1 silence inhibits the lipopolysaccharide-induced microglial apoptosis and inflammation

Isosibiricin Inhibits Microglial Activation by Targeting the Dopamine D1/D2 Receptor-Dependent NLRP3/caspase-1 Inflammasome Pathway

Regulation of Ubiquitin-Specific Processing Protease 8 Suppresses Neuroinflammation

MicroRNA-451 Attenuates the Inflammatory Response of Activated Microglia by Downregulating Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3.

Lipopolysaccharide-Induced Microglial Neuroinflammation: Attenuation by FK866.